Tevos Pharmaceuticals Llp

Tevos Pharmaceuticals Llp - pharma in Ahmedabad, Gujarat, India. FY 2026 financials and compliance.
LLPIN AAR-9087 Incorporated 13 February 2020 ROC Ahmedabad HQ Ahmedabad, Gujarat, India
Active Limited Liability Partnership pharma
Data last updated
Revenue · FY 2022
₹12.03 Lakh
Latest filing
EBITDA · FY 2022
*****
In full report
Net profit · FY 2022
*****
In full report
Contribution obligation
₹1 Lakh
As per LLP agreement
Paid-up contribution
-
Contribution received
Open charges
None
Secured borrowings
Company age
6 yrs
Est. 2020
Last financials
Mar 2023
Balance sheet date

About Tevos Pharmaceuticals Llp

Data last updated: 30 December 2025

Tevos Pharmaceuticals Llp is a limited liability partnership company based in Ahmedabad, Gujarat, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 13 February 2020, the LLP has been in operation for over 6 years.

Registered with ROC Ahmedabad under LLPIN AAR-9087.

Capital: a total obligation of contribution of ₹1 Lakh. It is led by designated partners including Mrugank Jatin Shah and Haresh Sevantilal Shah.

Accounts filed on 31 March 2023. Office: 108A Raghuvir Estate N.H. 8 At. Aslali, Ahmedabad, Gujarat, India – 382427.

As per the financials filed for FY 2022, the LLP reported a revenue of ₹12.03 Lakh.

The LLP is associated with 1 brand - Sweetmate.

Company Details of Tevos Pharmaceuticals Llp
LLPIN AAR-9087
Incorporation Date 13 February 2020
Total Obligation of Contribution ₹1 Lakh
ROC Ahmedabad
Company Status Active
Date of Last AGM 31 March 2024
Date of Balance Sheet 31 March 2023
Key People
Mrugank Jatin Shah Designated Partner Haresh Sevantilal Shah Designated Partner Jatin Sevantilal Shah Designated Partner
Contact Details
  • Email
    *****@*****.com
  • Telephone
    **************
  • Website
    **************
  • Social Media
    **************
  • Registered Address
    108A Raghuvir Estate N.H. 8 At. Aslali, Ahmedabad, Gujarat, India – 382427
  • Industry
    Pharma, Drug Formulation & Development
Company report
Tevos Pharmaceuticals Llp - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Tevos Pharmaceuticals Llp report

Financials, compliance, directors, charges, ownership and filings for Tevos Pharmaceuticals Llp in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Tevos Pharmaceuticals Llp

Tevos Pharmaceuticals Llp operates one associated brand: Sweetmate. These brands represent Tevos Pharmaceuticals Llp's diversified market presence and brand portfolio.

Brand Description Website
Sweetmate
Offers natural stevia-based sweeteners, jams, and drinks for health-conscious individuals. sweetmate.in

Competitors & Alternatives of Tevos Pharmaceuticals Llp

Brands and companies operating in the same space as Tevos Pharmaceuticals Llp include Stem Sugar, Wholesome, BioNeutra and 6 more.

Competitor Description Location Founded
Stem Sugar Stem Sugar Plant-based low-calorie sugar substitutes are manufactured from fibers. Cambridge, United Kingdom, United Kingdom 2017
Wholesome Wholesome Sweeteners brand Sugar Land, United States, United States 2001
BioNeutra BioNeutra Functional fibers for human digestion health are developed. Edmonton, Canada, Canada 2003
Green Valley Stevia Green Valley Stevia Herbal-based supplements for health and well-being are supplied. Nawanshahr, India, India 2010
Xilinat Xilinat Healthcare and nutrition products are offered by Xilinat brand. Mexico City, Mexico, Mexico 2003
Sweet Balance Sweet Balance Plant-based sugar substitute ingredients are developed for food applications. Tel Aviv, Israel, Israel 2021
Solens Solens Sweets and candies are offered by the Solens brand. Montbonnot Saint Martin, France, France 2020
MiraculeX MiraculeX Produces high-quality protein sweeteners for the food industry. San Francisco, United States, United States 2014
Sweetlife Foods Sweetlife Foods Produces high-quality stevia-based sweeteners for the food industry. Parganas, India, India 2018

Designated Partners of Tevos Pharmaceuticals Llp

Tevos Pharmaceuticals Llp is governed by 3 designated partners who oversee the company's operations and strategic decisions.

Current Designated Partners
Name Designation Appointment Date Tenure Status
Mrugank Jatin Shah
Also directs: Tevos Bioscience Llp, Farmadel Lifestyle Private Limited, Try Sweetmate Solutions Private Limited
Designated Partner 13 Feb 2020 6 Years 4 Months Current
Haresh Sevantilal Shah
Also directs: Tevos Bioscience Llp, Farmadel Lifestyle Private Limited
Designated Partner 13 Feb 2020 6 Years 4 Months Current
Jatin Sevantilal Shah
Also directs: Tevos Bioscience Llp
Designated Partner 13 Feb 2020 6 Years 4 Months Current
View all designated partners

Financials of Tevos Pharmaceuticals Llp FY 2023 filings available

Tevos Pharmaceuticals Llp reported revenue of ₹12.03 Lakh (up ) for FY 2022. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue
₹12.03 Lakh
EBITDA
*****
Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****
Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF
What Is the Ownership and Shareholding Structure of Tevos Pharmaceuticals Llp?

View Tevos Pharmaceuticals Llp's control and ownership data: shareholding patterns, funding details, FII information, directors and KMP remuneration, group structure, overseas investment and related data.

Shareholding Pattern (FY 2026)
Shareholding pattern chart
  • Promoters: **.**%
  • Public: **.**%
  • Others: **.**%
Shareholding Pattern over the Year
FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Promoters**.****.****.****.****.**
Public**.****.****.****.****.**
Others**.****.****.****.****.**

Full shareholding pattern with quarterly trends.

Charges & Borrowings Tevos Pharmaceuticals Llp

Tevos Pharmaceuticals Llp does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Tevos Pharmaceuticals Llp

View historical data on people associated with Tevos Pharmaceuticals Llp, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Tevos Pharmaceuticals Llp

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Tevos Pharmaceuticals Llp

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Tevos Pharmaceuticals Llp

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Tevos Pharmaceuticals Llp

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Tevos Pharmaceuticals Llp

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Tevos Pharmaceuticals Llp

MSME Payment Delays by Tevos Pharmaceuticals Llp

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Tevos Pharmaceuticals Llp

Subsidiaries & Group Companies of Tevos Pharmaceuticals Llp

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Tevos Pharmaceuticals Llp with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Tevos Pharmaceuticals Llp

MCA Filings & Documents of Tevos Pharmaceuticals Llp

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Tevos Pharmaceuticals Llp

Activity
31 Mar 2024
Tevos Pharmaceuticals Llp last Annual general meeting of members was held on 31 Mar 2024 as per latest MCA records.
Activity
31 Mar 2023
Tevos Pharmaceuticals Llp has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Ahmedabad.
Directors
13 Feb 2020
Mrugank Jatin Shah was appointed as a Designated Partner on 13 Feb 2020 & has been associated with this company since 6 years 4 months.
Directors
13 Feb 2020
Haresh Sevantilal Shah was appointed as a Designated Partner on 13 Feb 2020 & has been associated with this company since 6 years 4 months.
Directors
13 Feb 2020
Jatin Sevantilal Shah was appointed as a Designated Partner on 13 Feb 2020 & has been associated with this company since 6 years 4 months.
Activity
13 Feb 2020
Tevos Pharmaceuticals Llp was registered on 13 Feb 2020 with Roc Ahmedabad & aged 6 years 4 months as per MCA records.

Frequently Asked Questions about Tevos Pharmaceuticals Llp

Tevos Pharmaceuticals Llp is an active limited liability partnership in the pharma sector based in Ahmedabad, Gujarat, India. It was incorporated on 13 February 2020 (6+ years old) and is registered under LLPIN AAR-9087.

Tevos Pharmaceuticals Llp reported revenue of ₹12.03 Lakh for FY 2022.

The current designated partners of Tevos Pharmaceuticals Llp are:

The primary industry of Tevos Pharmaceuticals Llp is pharma. The LLP specifically operates in drug formulation and development. The LLP is currently active in this sector.

Tevos Pharmaceuticals Llp can be reached at the registered office: 108A Raghuvir Estate N.H. 8 At. Aslali, Ahmedabad, Gujarat, India – 382427.

The total obligation of contribution is ₹1 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available